[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/MONDO_0002009",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/MONDO_0002009"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://go.drugbank.com/drugs/DB00745"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Psychostimulants were associated with statistically significant improvement in depressive symptoms in major depressive disorder (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.13-1.78; P = 0.003) and bipolar disorder (OR, 1.42; 95% CI, 1.13-1.78; P = 0.003). Efficacy outcomes differed across the psychostimulants evaluated as a function of response rates: ar/modafinil (OR, 1.47; 95% CI, 1.20-1.81; P = 0.0002); dextroamphetamine (OR, 7.11; 95% CI, 1.09-46.44; P = 0.04); lisdexamfetamine dimesylate (OR, 1.21; 95% CI, 0.94-1.56; P = ns); methylphenidate (OR, 1.49; 95% CI, 0.88-2.54; P = ns). Efficacy outcomes also differed between agents used as adjunctive therapy (OR, 1.39; 95% CI, 1.19-1.64) or monotherapy (OR, 2.25; 95% CI, 0.67-7.52)."
    } ],
    "https://w3id.org/biolink/vocab/association_type" : [ {
      "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
    } ],
    "https://w3id.org/biolink/vocab/has_population_context" : [ {
      "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#cohort"
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/publications" : [ {
      "@id" : "https://pubmed.ncbi.nlm.nih.gov/28590365/"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://w3id.org/um/neurodkg/OffLabelIndication"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#cohort",
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Adults"
    } ],
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Cohort"
    } ]
  }, {
    "@id" : "https://go.drugbank.com/drugs/DB00745",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-7641-6446"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-05-26T16:48:01.072+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-7641-6446"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAZdZj78B6nKrP1Q00oFzsK07u7WdiY3sToz-H-H2nSgg"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "VlUHpfpsUx2NgnneXYiB/s1SAOpYOS+7GobLN/EvgvZDBVZAyT5aE6y+vwjEOC9+6dpHWMKm2xYctsEMgHVgfVKxEAp6Da9jgGEabKdttQbCnbx1sPn3O/inZes7BYHy2kh9Jfx8c1EqTXVbt0WsbcCaAvnEGb+vqlYObn8frUE="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAIgYwIbbYodttOPI0izYKdN00yKcC64EE_c8H8J749VE#pubinfo"
} ]